Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
nab-Sirolimus in Epithelioid Hemangioendothelioma
NCT07104331Phase 2Recruiting
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Start
- Feb 2026
- Primary completion
- Aug 2029
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-sirolimus in epithelioid hemangioendothelioma (EHE), sponsored by Sarcoma Alliance for Research through Collaboration. Started Feb 2026; status: recruiting.
02
Drugs
nab-sirolimus
03
Conditions
epithelioid hemangioendothelioma (EHE)
Beyond the preview
Go deeper on NCT07104331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07104331.